PSG12- HOSPITAL COST SAVINGS FROM SEVERITY-ADJUSTED LENGTH OF STAY FOLLOWING SURGERY FOR INTRA-ABDOMINAL INFECTION AND TREATMENT WITH PIPERACILLIN/ TAZOBACTAM OR IMIPENEM/CILASTATIN
Abstract
Authors
S Bjerke R Mallick K Clark M Wible E Zito R Guttman G Sillup